Catalina Capital Group LLC Acquires 166 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Catalina Capital Group LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 2,668 shares of the medical equipment provider’s stock after buying an additional 166 shares during the period. Catalina Capital Group LLC’s holdings in Intuitive Surgical were worth $1,311,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Norden Group LLC raised its stake in Intuitive Surgical by 32.4% during the first quarter. Norden Group LLC now owns 957 shares of the medical equipment provider’s stock worth $382,000 after acquiring an additional 234 shares in the last quarter. Richardson Financial Services Inc. bought a new position in Intuitive Surgical in the first quarter valued at approximately $46,000. Csenge Advisory Group grew its stake in shares of Intuitive Surgical by 16.4% during the first quarter. Csenge Advisory Group now owns 1,229 shares of the medical equipment provider’s stock worth $490,000 after purchasing an additional 173 shares during the period. Geneva Capital Management LLC boosted its stake in Intuitive Surgical by 20.3% during the 1st quarter. Geneva Capital Management LLC now owns 5,390 shares of the medical equipment provider’s stock worth $2,151,000 after acquiring an additional 911 shares during the last quarter. Finally, Advisory Alpha LLC acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $414,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, EVP Robert Desantis sold 240 shares of the company’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,558,968.56. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 68,246 shares of company stock valued at $33,839,308 over the last 90 days. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $515.17 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $269.49 and a 52-week high of $523.34. The company’s 50 day moving average price is $491.63 and its 200-day moving average price is $449.59. The company has a market capitalization of $183.49 billion, a P/E ratio of 82.82, a price-to-earnings-growth ratio of 4.98 and a beta of 1.39.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Citigroup boosted their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Finally, Truist Financial lifted their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.